BMJ  2005;330 (18 June), doi:10.1136/bmj.330.7505.0-c

Should everyone over 50 take aspirin prophylaxis?

On pages 1440 and 1442, two sides of the argument are presented on whether aspirin should be used for primary prevention of vascular disease in all people over a certain age, and what that age should be. Elwood and colleagues believe that evidence shows that aspirin should be taken from around 50 years of age, but they also argue that the topic should be widely discussed and that the final decision should lie with each individual person. Baigent is not convinced by the available evidence and argues that such practice could result in net harm.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Aspirin for everyone older than 50?: FOR

Peter Elwood, Gareth Morgan, Ginevra Brown, and Janet Pickering
BMJ 2005 330: 1440-1441. [Extract] [Full Text] [PDF]

Aspirin for everyone older than 50?: AGAINST

Colin Baigent
BMJ 2005 330: 1442-1443. [Extract] [Full Text]

Rapid Responses:

Read all Rapid Responses

Benefit of primary prevention still uncertain

Andreas Waltering
bmj.com, 17 Jun 2005 [Full text]

Are we medicating a nutritional deficiency?

Michael K. McMullen
bmj.com, 20 Jun 2005 [Full text]